Skip to content

How is Asia-Pacific reshaping global pharmaceutical manufacturing and supply chain strategy?

Sherma Ellis Daal, brand director –Pharma, Informa Markets, explores how Asia-Pacific is evolving from a low-cost manufacturing base into a global innovation hub, with Singapore leading in advanced pharma capabilities, AI, and next-gen drug delivery.

How is Asia-Pacific reshaping global pharmaceutical manufacturing and supply chain strategy?
Published: | 4 min read

Sherma Ellis Daal, brand director – Pharma, Informa Markets, explores how Asia-Pacific is evolving from a low-cost manufacturing base into a global innovation hub, with Singapore leading in advanced pharma capabilities, AI, and next-gen drug delivery.

Informa Markets

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information